GC Pharma Receives Korea’s MFDS Approval of GCFLU Quadrivalent (Influenza Vaccine) for persons 6 months and older0 Comments
YONGIN, South Korea, Sept. 30, 2018 /PRNewswire/ — GC Pharma (formerly known as Green Cross) announced today it has received... Read More →
GC LabCell and Feldan Therapeutics announce license agreement to develop next-generation NK cells for immunotherapy using Feldan Shuttle technology0 Comments
SEOUL, South Korea and QUÉBEC CITY, June 27, 2018 /CNW Telbec/ – GC LabCell (hereafter “GCLC”) and Feldan Therapeutics (hereafter “Feldan”) announced an agreement... Read More →
A Major Project in Canada
GC Mogam Inc.